Onxeo SA Financials
| C4X Stock | 0.05 0 4.55% |
Onxeo |
Understanding current and past Onxeo SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Onxeo SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Onxeo SA's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Onxeo SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Onxeo SA. Check Onxeo SA's Beneish M Score to see the likelihood of Onxeo SA's management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | Stuttgart Exchange |
| ISIN | FR0010095596 |
| Benchmark | Dow Jones Industrial |
You should never invest in Onxeo SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Onxeo Stock, because this is throwing your money away. Analyzing the key information contained in Onxeo SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Onxeo SA Key Financial Ratios
Onxeo SA's financial ratios allow both analysts and investors to convert raw data from Onxeo SA's financial statements into concise, actionable information that can be used to evaluate the performance of Onxeo SA over time and compare it to other companies across industries.Onxeo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Onxeo SA's current stock value. Our valuation model uses many indicators to compare Onxeo SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Onxeo SA competition to find correlations between indicators driving Onxeo SA's intrinsic value. More Info.Onxeo SA is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Onxeo SA is about 10,941,272 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Onxeo SA's earnings, one of the primary drivers of an investment's value.Onxeo SA Systematic Risk
Onxeo SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Onxeo SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Onxeo SA correlated with the market. If Beta is less than 0 Onxeo SA generally moves in the opposite direction as compared to the market. If Onxeo SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Onxeo SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Onxeo SA is generally in the same direction as the market. If Beta > 1 Onxeo SA moves generally in the same direction as, but more than the movement of the benchmark.
Onxeo SA January 6, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Onxeo SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Onxeo SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Onxeo SA based on widely used predictive technical indicators. In general, we focus on analyzing Onxeo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Onxeo SA's daily price indicators and compare them against related drivers.
| Downside Deviation | 13.52 | |||
| Information Ratio | 0.0234 | |||
| Maximum Drawdown | 103.8 | |||
| Value At Risk | (28.00) | |||
| Potential Upside | 28.2 |
Additional Tools for Onxeo Stock Analysis
When running Onxeo SA's price analysis, check to measure Onxeo SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Onxeo SA is operating at the current time. Most of Onxeo SA's value examination focuses on studying past and present price action to predict the probability of Onxeo SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Onxeo SA's price. Additionally, you may evaluate how the addition of Onxeo SA to your portfolios can decrease your overall portfolio volatility.